Open Orphan PLC Result of AGM (5670O)
October 02 2019 - 10:58AM
UK Regulatory
TIDMORPH
RNS Number : 5670O
Open Orphan PLC
02 October 2019
02 October 2019
Open Orphan plc
("Open Orphan" or the "Company")
Result of AGM
Open Orphan, a European-focussed, rare and orphan drug
consulting services platform, announces that all the resolutions
put to shareholders at the Annual General Meeting of the Company
held earlier today were duly passed.
Enquiries:
Open Orphan plc Tel: +353 1 644 0007
Cathal Friel, Chief Executive Officer
Arden Partners (Nominated Adviser and Joint Broker) Tel: +44
(0)20 7614 5900
John Llewellyn-Lloyd / Ruari McGirr / Benjamin Cryer
Davy (Euronext Growth Adviser and Joint Broker) Tel: +353 (0)1
679 6363
Anthony Farrell (Corporate Finance)
Camarco (Financial PR) Tel: +44 (0)20 3757 4980
Tom Huddart / Billy Clegg / Dan Sherwen
Notes to Editors:
Open Orphan plc is a European-focused, rare and orphan drug
consulting services platform. The Company intends to roll up a
number of orphan drug services business. Open Orphan has two data
driven digital platforms, a Genomic Health Data Platform, which is
establishing a rare disease database and a Virtual Rep platform
enabling pharmaceutical companies to engage key opinion leaders and
physicians. The Company is targeting rapid growth in one of the
fastest growing sectors in the global pharmaceutical industry
targeting under-supplied treatment for life threatening or very
serious diseases and rare disorders.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGUGGAAUUPBGCP
(END) Dow Jones Newswires
October 02, 2019 10:58 ET (14:58 GMT)
Venn Life Sciences (LSE:VENN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Venn Life Sciences (LSE:VENN)
Historical Stock Chart
From Apr 2023 to Apr 2024
